Federal Lawsuit In Arkansas Considering RICO Act: Is This The End Of Medical Marijuana In The State?

On August 4, a proposed initiative to legalize recreational marijuana was turned down by the State Board of Election Commissioners. The commissioners dismissed the amendment, with one of the main issues being the level of THC allowed in cannabis edibles. Now, THC levels are generating a new controversy over medical marijuana.

A federal lawsuit filed on July 12 in Little Rock, is now looking to use federal Racketeer Influenced and Corrupt Organizations (RICO) statutes, which were created to target organized crime. Arkansas is seeking to use RICO to go after medical marijuana suppliers in the state that allegedly sold cannabis with lower-than-advertised potency.

Pete Edwards, Don Plumlee and Jakie Hanan, the plaintiffs, argue that at some point they bought medical marijuana that had THC 25% lower than what was advertised, and, asked to be ruled a class action, reported wreg.com

In addition, the plaintiffs argued that the marijuana business is subject to the federal RICO Act since large-scale marijuana production and sale is illegal under federal law.

“If successful, it could ultimately impact accessibility to medical marijuana in the state,” reported local media.

The lawsuit names California-based marijuana testing service Steep Hill, Inc. and its Arkansas subsidiary, Steep Hill Arkansas, the co-owners of Steep Hill Arkansas, Dr. Brandon Thorton and Brent Whittington, Osage Creek Cultivation, Bold Team LLC, and Natural State Medicinal

Photo by Mick Haupt on Unsplash

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.